Results 291 to 300 of about 38,272 (314)
Some of the next articles are maybe not open access.

Dapagliflozine

Nursing, 2021
openaire   +1 more source

Gut-kidney interaction reinforces dapagliflozin-mediated alleviation in diabetic nephropathy.

American Journal of Physiology - Cell Physiology
Intestinal microbiota are pathophysiologically involved in diabetic nephropathy (DN). Dapagliflozin, recognized for its blood glucose-lowering effect, has demonstrated efficacy in improving DN. However, the mechanisms beyond glycemic control that mediate
Yinhua Ni   +9 more
semanticscholar   +1 more source

Dapagliflozin mitigates oxidative stress, inflammatory, and histopathological markers of aging in mice

Journal of Medicine and Life
Aging, a complex physiological process affecting all living things, is a major area of research, particularly focused on interventions to slow its progression.
E. M. Shihab   +2 more
semanticscholar   +1 more source

Dapagliflozin

Reactions Weekly, 2017
  +4 more sources

Dapagliflozin

Reactions Weekly, 2016
  +4 more sources

Dapagliflozin

Reactions Weekly, 2020
  +4 more sources

Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial

Nature Medicine, 2022
Orly Vardeny   +2 more
exaly  

Dapagliflozin

Reactions Weekly, 2023
  +4 more sources

Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial

Lancet Diabetes and Endocrinology,the, 2021
Mikhail N Kosiborod   +2 more
exaly  

Efficacy and Safety of Dapagliflozin in Patients With Acute Heart Failure.

Journal of the American College of Cardiology
Z. Cox   +14 more
semanticscholar   +1 more source
medicine
diabetes mellitus
endocrinology
internal medicine
type 2 diabetes
heart failure
chemistry
cardiology
pharmacology
previous   28  29  30  31  32  

Home - About - Disclaimer - Privacy